-+ 0.00%
-+ 0.00%
-+ 0.00%

Phio Pharmaceuticals Director David H. Deming Reports Acquisition of $10,066.20 in Common Shares

PUBT·11/12/2026 14:53:19
Listen to the news
Phio Pharmaceuticals Director David H. Deming Reports Acquisition of $10,066.20 in Common Shares
  • Phio Pharmaceuticals director David H. Deming purchased 12,000 common shares, bringing his direct beneficial ownership to 49,800 shares.
  • Purchases comprised 6,800 shares at $0.8395 per share and 5,200 shares at $0.838 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-008544), on November 12, 2026, and is solely responsible for the information contained therein.